Inhibition of 5-HT3 receptor function by imidazolines in mouse neuroblastoma cells: potential involvement of σ2 binding sites

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 354, Issue 3, 1996, Pages 245-252

  Molderings, G J ^a   Schmidt, K ^a   Bonisch H ^a   Gothert M ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Binding site; 5 HT3 receptor; 3H DTG binding sites; 3H GR65630 binding sites; Imidazoline receptor; Ligand gated ion channels; N1E 115 cells

Indexed keywords

1,3 BIS(2 METHYLPHENYL)GUANIDINE; 2 (2 METHOXY 1,4 BENZODIOXAN 2 YL) 2 IMIDAZOLINE; 3 (5 METHYL 1H IMIDAZOL 4 YL) 1 (1 METHYL 1H INDOL 3 YL) 1 PROPANONE; 4 CHLORO 2 (2 IMIDAZOLIN 2 YLAMINO)ISOINDOLINE; ADRENALIN; AGMATINE; ANTAZOLINE; ARCAINE; CIRAZOLINE; CLONIDINE; DIZOCILPINE; EFAROXAN; GUANIDINE; HALOPERIDOL; IDAZOXAN; IFENPRODIL; IMIDAZOLIDINE DERIVATIVE; KETAMINE; MOXONIDINE; NAPHAZOLINE; ONDANSETRON; PRECLAMOL; SEROTONIN 3 RECEPTOR; SPERMIDINE; TOLAZOLINE; DRUG RECEPTOR; GUANIDINE DERIVATIVE; IMIDAZOLE DERIVATIVE; INDOLE DERIVATIVE; ION CHANNEL; LIGAND; SEROTONIN; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; SUBSTANCE P;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; ION CURRENT; MOUSE; MULTIPLE REGRESSION; NEUROBLASTOMA CELL; NONHUMAN; ANIMAL; CELL CULTURE; CELL MEMBRANE; CHANNEL GATING; DOSE RESPONSE; DRUG EFFECT; METABOLISM;

ANIMALS; BINDING SITES; CELL MEMBRANE; DOSE-RESPONSE RELATIONSHIP, DRUG; GUANIDINE; GUANIDINES; IMIDAZOLES; INDOLES; ION CHANNEL GATING; ION CHANNELS; LIGANDS; MICE; ONDANSETRON; RECEPTORS, DRUG; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN ANTAGONISTS; SUBSTANCE P; TUMOR CELLS, CULTURED;

EID: 0029658644     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. 14C-guanidinium ions in neuroblastoma cells. Naunyn-Schmiedeberg's Arch Pharmacol 345 [Suppl]: R112
2. 3 receptor of N1E-115 neuroblastoma cells. Naunyn-Schmiedeberg's Arch Pharmacol 347:125-132
3. 14C]-guanidinium. Br J Pharmacol 108:436-442
4. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
5. Catterall WA, Nirenberg M (1973) Sodium uptake associated with activation of action potential ionophores of cultured neuroblastoma and muscle cells. Proc Natl Acad Sci USA 70:3759-3763
6. 2-adrenoceptors and imidazoline-binding sites in the control of insulin secretion. Clin Sci 85:671-677
7. 50) of an enzyme reaction. Biochem Pharmacol 22:3099-3108
8. Cull-Candy SG, Mathie A, Powis DA (1988) Acetylcholine receptor channels and their block by clonidine in cultured bovine chromaffin cells. J Physiol 402:255-278
9. Dunne MJ (1991) Block of ATP-regulated potassium channels by phentolamine and other α-adrenoceptor antagonists. Br J Pharmacol 103:1847-1850
10. 3 receptor ligands and substance P. J Neurochem 60:2059-2067
11. 1Imidazoline receptors: definition, characterization, distribution and transmembrane signaling. Ann New York Acad Sci 763:22-42
12. Georg A, Friedl AJ (1991) Identification and characterization of two sigma-like binding sites in the mouse neuroblastoma × rat glioma hybrid cell line NG108-15. J Pharmacol Exp Ther 259:479-483
13. 3 receptor antagonist. Br J Pharmacol 114:269-274
14. 3H]13-di(2-toly1)guanidine binding sites in porcine gastric fundic mucosa. J Pharmacol Exp Ther 269:905-910
15. Hashimoto K, London ED (1995) Interactions of erythro-ifenprodil. threo-ifenprodil, erythro-iodoifenprodil and eliprodil with subtypes of sigma receptors. Eur J Pharmacol 273:307-310
16. 1 receptors. Med Res Rev 10:441-475
17. Li G, Regunathan S, Barrow CJ, Eshraghi J, Cooper R, Reis DJ (1994) Agmatine: an endogenous clonidine-displacing substance in the brain. Science 263:966-969
18. Loring RH (1990) Agmatine acts as an antagonist of neuronal nicotinic receptors. Br J Pharmacol 99: 207-211
19. Malave A, Borowitz JL, Yim GKW (1983) Block by phencyclidine of acetylcholine and barium induced adrenal catecholamine secretion. Life Sci 33:511-516
20. 3 receptor a serotonin-gated ion channel. Science 254:432-437
21. 3H]SKF-10047 binding sites (sigma sites) from rat liver membranes. J Pharmacol Exp Ther 257:547-554
22. McCool BA, Lovinger DM (1995) Ifenprodil inhibition of the 5-hydroxytryptamine3 receptor. Neuropharmacology 34:621-629
23. 2-imidazoline binding sites. Naunyn-Schmiedeberg's Arch Pharmacol 351:507-516
24. 2-imidazoline binding sites to inhibitory effects of imidazolines on ligand-gated ion channels: an investigation in the adrenal medulla and in neuroblastoma cells. Ann New York Acad Sci 763:420-432
25. 3H]clonidine binding sites in rat stomach: high affinity of imidazolines. guanidines and sigma ligands. NaunynSchmiedeberg's Arch Pharmacol 351:561-564
26. Musgrave IF, Krautwurst D, Hescheler J, Schultz G (1995) Clonidine and cirazoline inhibit activation of nicotinic channels on PC-12 cells. Ann New York Acad Sci 763:272-281
27. Nutt DJ, French N, Handley S, Hudson A, Husbands S, Jackson H, Jordan S, Lalies MD, Lewis J, Lione L, Mallard N, Pratt J (1995) Functional studies of specific imidazoline-2 receptor ligands. Ann New York Acad Sci 763:125-139
28. Ohara-Imaizumi M, Kumakura K (1992) Effects of imidazole compounds on catecholamine release in adrenal chromaffin cells. Cell Mol Neurobiol 12:273-283
29. Ohara-Imaizumi M, Miyakawa Y, Kumakura K (1988) Pertussis toxin attenuates clonidine inhibition of calecholamine release in adrenal chromaffin cells. Neurosci Lett 93:294-299
30. Olmos G, Kulkarni RN, Huque M, MacDermot J (1994) Imidazolines stimulate release of insulin from RIN-5AH cells independently from imidazoline I1 and I2 receptors. Eur J Pharmacol 262:41-18
31. Parini A, Moudanos G, Pizzinat N, Lanier SM (1996) The elusive family of imidazoline binding sites. Trends Pharmacol Sci 17:13-16
32. Paul IA, Basile AS, Rojas E, Yondim MBH, De Costa B, Skolnick P, Pollard HB, Kuijpers GAJ (1993) Sigma receptors modulate nicotinic receptor function in adrenal chromaffin cells. FASEB J 7: 1171-1178
33. 2-Adrenoceptors do not regulate catecholamine secretion by bovine medullary cells: a study with clonidine. Mol Pharmacol 29:134-141
34. Purifoy JA, Holz RW (1984) The effects of ketamine, phencyclidine and lidocaine on catecholamine secretion from cultured bovine chromaffin cells. Life Sci 35:1851-1857
35. Reis DJ, Li G, Regunathan S (1995) Endogenous ligands of imidazoline receptors: classic and immunoreactive clonidine-displacing substance and agmatine. Ann New York Acad Sci 763:295-313
36. Reiser G, Folkers K, Hamprecht B (1982) Substance P enhances cation permeability of neuronal cell lines. Regul Pept 5:85-93
37. Reiser G, Hamprecht B (1989) Substance P and serotonin act synergistically to activate a cation permeability in a neuronal cell line. Brain Res 479:40-48
38. +-channel preparations from mouse cerebral cortex. Eur J Pharmacol 188: 33-41
39. Rock DM (1995) Polyamine regulation of N-methyl-D-aspartate receptor channels. Annu Rev Pharmacol Toxicol 35:463-482
40. Sachs L (1984) Angewandte Statistik. 6th edn. Springer. Berlin Heidelberg New York Tokyo.
41. 2-adrenoceptor agonists of the secretion of catecholamines from isolated adrenal medullary cells. Naunyn-Schmiedeberg's Arch Pharmacol 324:15-19
42. Shaw GG, Pateman AJ (1973) The regional distribution of the polyamines spermidine and sperrnine in brain. J Neurochem 20:1225-1230
43. Vilner BJ, John CS, Bowen WD (1995) Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent cell lines. Cancer Res 55:408-413
44. Wan DCC, Powis DA, Marley PD, Livett BG (1988) Effects of α-and β-adrenoceptor agonists and antagonists on ATP and catecholamine release and desensitization of the nicotinic response in bovine adrenal chromaffin cells. Biochem Pharmacol 37:725-736
45. Walker JM, Bowen WD, Walker FO, Matsumoto RR, De Costa B, Rice KC (1990) Sigma receptors: biology and function. Pharmacol Rev 42:355-402
46. Weber E, Sonders M, Quarum M, McLean S, Pou S, Keana JFW (1986) 1.3-Di(2-(5-3H)tolyl)guanidine: A selective ligand that labels sigma-type receptors for psychotomimetic opiates and antipsychotic drugs. Proc Natl Acad Sci USA 83:8784-8788